Revenue by Geography
Rest of World Revenue
+0.52%
+5.33%
China Revenue
+1.41%
+15.03%
Other North American Operations (NAO) Revenue
+0.77%
+7.99%
Revenue
Victoza Revenue
+1.13%
+11.91%
Total Insulin Revenue
+2.97%
+33.94%
Total Obesity Care Revenue
-0.61%
-5.91%
Rare Disease Revenue
-0.02%
-0.17%
Other Diabetes Care Revenue
-1.91%
-17.56%
Rybelsus Revenue
-1.8%
-16.64%
EBIT
Diabetes & Obesity Care Operating Profit
+3.04%
+34.93%
Rare Disease Operating Profit
-0.35%
-3.47%
